Overview

A Study to Assess the Safety of Brexanolone in the Treatment of Adolescent Female Participants With Postpartum Depression (PPD)

Status:
Completed

Trial end date:
2021-01-08

Target enrollment:

Participant gender:

Summary

This is a multi-center study evaluating the safety, tolerability, and pharmacokinetics of brexanolone in the treatment of adolescent female participants with postpartum depression.

Phase:

Phase 3

Details

Lead Sponsor:

Sage Therapeutics

Treatments:

Brexanolone